홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → Hydrochloric Acid

HRID 625050
인쇄

반응식

HRID 625050 반응식
[N:1]1[C:6]2[CH2:7][S:8][CH2:9][C:5]=2[C:4]([N:10]2[CH2:15][CH2:14][N:13](C(OC(C)(C)C)=O)[CH2:12][CH2:11]2)=[N:3][CH:2]=1.[ClH:23]>C(Cl)Cl>[N:10]1([C:4]2[C:5]3[CH2:9][S:8][CH2:7][C:6]=3[N:1]=[CH:2][N:3]=2)[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]1.[ClH:23]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 313Hydrochloric AcidHCID 67457495Tert-butyl 4-(5,7-dihydrothieno[3,4-d]pyrimidin-4-yl)piperazine-1-carboxylate

생성물 2

HCID 313Hydrochloric Acid수율 99%HCID 67459054HCID 67459054, 화합물

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

To a solution of tert-butyl 4-(5,7-dihydrothieno[3,4-d]pyrimidin-4-yl)piperazine-1-carboxylate (0.41 g, 1.3 mmol) in CH2Cl2 (20 mL) was added HCl (4M in dioxane, 5 mL). The mix was stirred at room temperature for 4 hours. The solvent was removed to afford 4-(piperazin-1-yl)-5,7-dihydrothieno[3,4-d]pyrimidine as HCl salt (0.28 g, 99%). MS (APCI+) [M+H]+ 223.

후처리

  1. customThe solvent was removed

출처 및 근거

ORD 기록
ord-3d93226bb60b489891d258d9239f234c
출처 데이터셋
uspto-grants-2016_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09303040B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트